A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Status:
Terminated
Trial end date:
2014-02-19
Target enrollment:
Participant gender:
Summary
The study was primarily designed to determine objective response, progression-free survival
(PFS), and the safety and tolerability of R1507 in participants with recurrent or refractory
Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas
including alveolar soft part sarcoma, desmoplastic small round cell tumor, extraskeletal
myxoid chondrosarcoma, clear cell sarcoma, and myxoid liposarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Hoffmann-La Roche
Collaborator:
Sarcoma Alliance for Research through Collaboration